Maven Securities LTD Buys 16,500 Shares of GE HealthCare Technologies Inc. $GEHC

Maven Securities LTD raised its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 194.1% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 25,000 shares of the company’s stock after acquiring an additional 16,500 shares during the period. Maven Securities LTD’s holdings in GE HealthCare Technologies were worth $1,878,000 at the end of the most recent quarter.

A number of other institutional investors have also recently modified their holdings of GEHC. Vanguard Group Inc. increased its position in shares of GE HealthCare Technologies by 1.4% in the second quarter. Vanguard Group Inc. now owns 52,107,758 shares of the company’s stock worth $3,859,622,000 after purchasing an additional 703,903 shares during the period. Dodge & Cox raised its stake in GE HealthCare Technologies by 16.8% in the third quarter. Dodge & Cox now owns 27,517,311 shares of the company’s stock valued at $2,066,550,000 after purchasing an additional 3,949,361 shares in the last quarter. Capital Research Global Investors lifted its position in GE HealthCare Technologies by 25.0% during the third quarter. Capital Research Global Investors now owns 24,972,556 shares of the company’s stock worth $1,875,400,000 after purchasing an additional 4,998,154 shares during the period. State Street Corp lifted its position in GE HealthCare Technologies by 1.9% during the second quarter. State Street Corp now owns 19,660,742 shares of the company’s stock worth $1,456,271,000 after purchasing an additional 372,755 shares during the period. Finally, Hotchkis & Wiley Capital Management LLC grew its stake in GE HealthCare Technologies by 17.1% during the third quarter. Hotchkis & Wiley Capital Management LLC now owns 8,432,374 shares of the company’s stock worth $633,271,000 after buying an additional 1,232,828 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors.

GE HealthCare Technologies Price Performance

GEHC stock opened at $72.34 on Wednesday. The company has a market capitalization of $32.97 billion, a P/E ratio of 15.86, a PEG ratio of 1.59 and a beta of 1.03. The company has a fifty day moving average price of $80.24 and a 200-day moving average price of $78.52. The company has a debt-to-equity ratio of 0.91, a quick ratio of 1.13 and a current ratio of 1.37. GE HealthCare Technologies Inc. has a 52-week low of $57.65 and a 52-week high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, topping the consensus estimate of $1.40 by $0.04. The company had revenue of $5.70 billion for the quarter, compared to analysts’ expectations of $5.60 billion. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. GE HealthCare Technologies’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. As a group, equities analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be given a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date is Thursday, April 2nd. GE HealthCare Technologies’s payout ratio is 3.07%.

Wall Street Analyst Weigh In

Several equities analysts have commented on the stock. Wells Fargo & Company raised their target price on shares of GE HealthCare Technologies from $95.00 to $97.00 and gave the company an “overweight” rating in a report on Thursday, February 5th. Morgan Stanley increased their price target on shares of GE HealthCare Technologies from $80.00 to $85.00 and gave the stock an “equal weight” rating in a research report on Wednesday, February 4th. The Goldman Sachs Group reissued a “buy” rating and issued a $98.00 price objective on shares of GE HealthCare Technologies in a research note on Friday, January 9th. BTIG Research boosted their price objective on shares of GE HealthCare Technologies from $87.00 to $91.00 and gave the company a “buy” rating in a research report on Wednesday, February 4th. Finally, Piper Sandler upped their target price on GE HealthCare Technologies from $91.00 to $94.00 and gave the stock an “overweight” rating in a research note on Friday, January 30th. Seven analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $92.17.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.